Aurora Cannabis Pioneers Genetic Breakthrough Against Mildew
NASDAQ | TSX: ACB
Groundbreaking research at Aurora Coast elevates cannabis science to new heights.
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) proudly announces a significant breakthrough in the fight against powdery mildew, a prevalent fungal disease that threatens cannabis crops globally. This innovation stems from extensive research conducted at Aurora's cutting-edge facility, Aurora Coast, recognized for its commitment to advancing cannabis science.
Lana Culley, Aurora's Vice President of Innovation and International Operations, expressed enthusiasm about the findings, stating, "This discovery provides an essential solution for the cannabis industry. At Aurora Coast, our mission is to add value to our proprietary cannabis cultivars, and this will help manage disease within cannabis production efficiently. This achievement highlights our dedication to scientific excellence, setting us apart from others in the market."
The discovery was spearheaded by Jose Celedon, Principal Scientist of Breeding and Genetics at Aurora, alongside a team from The University of British Columbia. Their research emphasizes that breeding for genetic resistance to significant crop diseases is a sustainable approach to managing diseases and enhancing production efficiency, particularly when synthetic pesticide use is restricted.
This novel genetic marker technology, presently integrated into Aurora's breeding programs, promises to yield powdery mildew-resistant cultivars. With commercial exploration set for this year, these cultivars may redefine cannabis cultivation standards.
Remarkably, the advancements achieved through this genetic research not only boost potency and yield but also enhance overall production quality while driving down costs. Aurora’s strategic approach deviates from traditional breeding limitations, creating innovative cultivation methods and opening new market opportunities worldwide.
Aurora Cannabis is committed to improving biosecurity at production facilities, aiming to minimize production costs while improving product quality. The effectiveness of this breakthrough aligns with Aurora's ongoing commitment to scientific research and innovation, further solidifying its position as a leading player in the cannabis industry.
To protect this discovery, international patent applications have been filed, securing Aurora’s intellectual property and leadership in this innovative area.
About Aurora Cannabis Inc.
Aurora is dedicated to expanding access to cannabis, serving both medical and consumer markets globally, including Canada and other regions such as Europe, Australia, and New Zealand. The company, headquartered in Edmonton, Alberta, strives to enhance the lives of individuals through high-quality cannabis products. Aurora’s diverse portfolio encompasses notable brands for both adult-use and medical cannabis, including Drift, San Rafael '71, Daily Special, Tasty's, and MedReleaf, along with its international brands.
Furthermore, Aurora maintains a significant interest in Bevo Farms Ltd., which stands as North America's leading supplier of propagated agricultural plants. The drive for innovation in science and the continuous delivery of high-quality products ensure that Aurora's brands lead in the medical, wellness, and recreational markets.
Aurora’s common shares trade on the NASDAQ and TSX under the symbol "ACB." Follow Aurora on their official website and social media channels for the latest updates.
Frequently Asked Questions
What is the recent breakthrough announced by Aurora Cannabis?
Aurora Cannabis has discovered a genetic source of resistance against powdery mildew, promising to improve cannabis cultivation.
How does this breakthrough impact cannabis production?
This discovery aims to enhance biosecurity, reduce production costs, and improve overall product quality in cannabis farming.
Who led the research for this genetic breakthrough?
The research was led by Jose Celedon, Aurora's Principal Scientist of Breeding and Genetics, in collaboration with The University of British Columbia.
Are these findings protected legally?
Yes, Aurora has filed international patent applications to protect the genetic breakthrough related to powdery mildew resistance.
What are some brands under Aurora Cannabis?
Aurora's portfolio includes various brands like Drift, San Rafael '71, and MedReleaf, catering to both medical and consumer markets.
